4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0000950170-25-048601
Chief Financial Officer acquired 66,100 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lucera Erick Chief Financial Officer | 2025-03-31 | Grant or award | +66,100 | 66,100 | D | ||
| Derivatives | |||||||
| Lucera Erick Chief Financial Officer | 2025-03-31 | Grant or award · Stock Option (Right to Buy) | +214,500 | 214,500 | D | ||
Loading xslF345X05/ownership.xml…